LYSODREN 500 mg, comprimé — 1 flacon(s) polyéthylène haute densité (PEHD) de 100 comprimé(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400956579402 -
CIP7
5657940 -
CIS
66435544 -
Registration number
EU/1/04/273
What the source publishes
- Holder
- ESTEVE PHARMACEUTICALS (ESPAGNE)
- Active ingredients
- MITOTANE
- Form
- comprimé
- Package
- 1 flacon(s) polyéthylène haute densité (PEHD) de 100 comprimé(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- prescription réservée aux spécialistes et services PEDIATRIE ; prescription réservée aux spécialistes et services ENDOCRINOLOGIE ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2004-04-28
- Prescription
- Prescription or restricted
Names this record is found by
- LYSODREN 500 mg, comprimé — 1 flacon(s) polyéthylène haute densité (PEHD) de 100 comprimé(s)
- LYSODREN 500 mg, comprimé
- MITOTANE
Complete source data
{
"cis": "66435544",
"cip7": "5657940",
"form": "comprimé",
"name": "LYSODREN 500 mg, comprimé — 1 flacon(s) polyéthylène haute densité (PEHD) de 100 comprimé(s)",
"cip13": "3400956579402",
"holder": "ESTEVE PHARMACEUTICALS (ESPAGNE)",
"routes": [
"orale"
],
"holders": [
"ESTEVE PHARMACEUTICALS (ESPAGNE)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": null,
"authorisedOn": "2004-04-28",
"compositions": [
{
"name": "MITOTANE",
"nature": "SA",
"strength": "500 mg",
"linkageNumber": "1",
"substanceCode": "84359",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "prescription réservée aux spécialistes et services PEDIATRIE ; prescription réservée aux spécialistes et services ENDOCRINOLOGIE ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
"dispensingFee": null,
"medicinePrice": null,
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "LYSODREN 500 mg, comprimé",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "1 flacon(s) polyéthylène haute densité (PEHD) de 100 comprimé(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [],
"marketingDeclaredOn": "2004-07-12",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"MITOTANE"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"prescription réservée aux spécialistes et services PEDIATRIE",
"prescription réservée aux spécialistes et services ENDOCRINOLOGIE",
"prescription réservée aux spécialistes et services MEDECINE INTERNE",
"prescription hospitalière",
"liste I",
"prescription réservée aux médecins compétents en CANCEROLOGIE"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/04/273",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400956579402"